Literature DB >> 15033523

Sensitive genetic biomarkers for determining apoptosis in the brown bullhead (Ameiurus nebulosus).

C R Busch1, D D Heath, A Hubberstey.   

Abstract

Biomarkers are necessary for monitoring environmentally induced alterations at the molecular level in order to assess the impact of xenobiotic compounds on organism health. Apoptosis is a highly regulated cellular process that controls programmed cell death and is involved in tumor formation. Apoptosis thus may provide the basis for developing biomarkers for use in the field of ecotoxicology to monitor non-lethal levels of xenobiotic induced cellular stress and toxicity. This study shows that a brown bullhead (Ameiurus nebulosus) fibroblast cell line (BB-2) responds to known apoptotic inducers (staurosporine, cycloheximide, and tumor necrosis factor alpha (TNF-alpha)), as characterized by terminal deoxynucleotidyl transferase (TdT)-mediated dUTP digoxigenin nick end-labelling (TUNEL). Furthermore, we characterized the apoptotic process using a series of newly identified bullhead genetic markers. Exposure to protein kinase C inhibitors altered the transcription of TF-cell apoptosis-related protein (TFAR)-15 and p23 with no effect on p53, inhibitor of apoptosis protein (IAP), or PNAS-2. Inhibition of protein synthesis caused a consistent reduction in the transcription of p53 and PNAS-2. This study demonstrates that our novel transcriptional markers are sensitive biomarkers for the study of the effects of xenobiotic chemicals on apoptosis in the brown bullhead.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15033523     DOI: 10.1016/j.gene.2004.01.004

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  8 in total

Review 1.  Update on the molecular genetics of vascular anomalies.

Authors:  Qing K Wang
Journal:  Lymphat Res Biol       Date:  2005       Impact factor: 2.589

Review 2.  Recent insights into cerebral cavernous malformations: a complex jigsaw puzzle under construction.

Authors:  Eva Faurobert; Corinne Albiges-Rizo
Journal:  FEBS J       Date:  2010-01-22       Impact factor: 5.542

3.  CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations.

Authors:  Xiangjian Zheng; Chong Xu; Annarita Di Lorenzo; Benjamin Kleaveland; Zhiying Zou; Christoph Seiler; Mei Chen; Lan Cheng; Jiping Xiao; Jie He; Michael A Pack; William C Sessa; Mark L Kahn
Journal:  J Clin Invest       Date:  2010-07-01       Impact factor: 14.808

Review 4.  Genetics of cerebral cavernous malformations.

Authors:  Nicholas W Plummer; Jon S Zawistowski; Douglas A Marchuk
Journal:  Curr Neurol Neurosci Rep       Date:  2005-09       Impact factor: 5.081

5.  Apoptotic functions of PDCD10/CCM3, the gene mutated in cerebral cavernous malformation 3.

Authors:  Leiling Chen; Gamze Tanriover; Hiroko Yano; Robert Friedlander; Angeliki Louvi; Murat Gunel
Journal:  Stroke       Date:  2009-02-26       Impact factor: 7.914

6.  Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations.

Authors:  F Bergametti; C Denier; P Labauge; M Arnoult; S Boetto; M Clanet; P Coubes; B Echenne; R Ibrahim; B Irthum; G Jacquet; M Lonjon; J J Moreau; J P Neau; F Parker; M Tremoulet; E Tournier-Lasserve
Journal:  Am J Hum Genet       Date:  2004-11-12       Impact factor: 11.025

7.  PDCD10 promotes the aggressive behaviors of pituitary adenomas by up-regulating CXCR2 and activating downstream AKT/ERK signaling.

Authors:  Jingdian Liu; Junwen Wang; Weidong Tian; Yu Xu; Ran Li; Kai Zhao; Chao You; Yuan Zhu; Joerg Walter Bartsch; Hongquan Niu; Huaqiu Zhang; Kai Shu; Ting Lei
Journal:  Aging (Albany NY)       Date:  2022-08-11       Impact factor: 5.955

8.  HOXB1 restored expression promotes apoptosis and differentiation in the HL60 leukemic cell line.

Authors:  Marina Petrini; Federica Felicetti; Lisabianca Bottero; Maria Cristina Errico; Ornella Morsilli; Alessandra Boe; Alessandra De Feo; Alessandra Carè
Journal:  Cancer Cell Int       Date:  2013-10-22       Impact factor: 5.722

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.